放射性脑膜瘤的生长速率与临床结局:治疗或主动监测的回顾性研究
中位绝对生长速率为0.62 cm³/年,中位相对生长速率为72%/年;结论认为放射性脑膜瘤发现后生长速率高,仅对症状性或快速生长的脑膜瘤推荐手术,术后复发风险高。
要点
- 放射性脑膜瘤中位绝对生长速率0.62 cm³/年,中位相对生长速率72%/年。
- 手术指征限于症状性或快速生长的脑膜瘤。
- 术后进展风险高,中位进展时间28个月。
核心结论
- 放射性脑膜瘤发现后表现出高的绝对和相对生长速率。
- 仅对症状性或快速生长的脑膜瘤推荐手术。
- 手术后复发风险高。
研究设计与样本
- 回顾性研究,纳入2007—2019年一家三级神经科学中心管理的放射性脑膜瘤患者。
- 从诊断时及后续间隔扫描测量肿瘤体积,采用线性混合效应模型确定生长速率。
主要发现
- 平均放疗剂量41 Gy(SD=14.9),潜伏期34.4年(SD=13.7)。
- 中位绝对生长速率0.62 cm³/年,中位相对生长速率72%/年。
- 手术的放射性脑膜瘤临床侵袭性强,首次切除WHO 2级占43.6%,术后进展占41%。
- 中位进展时间28个月(IQR 13—60.5);发现时肿瘤较大与生长相关(HR 1.2,95%CI 1.0—1.5,P=0.039),但与术后进展无关(HR 2.2,95%CI 0.7—6.6,P=0.181)。
关键数值与推荐
- 手术推荐仅用于症状性或快速生长的脑膜瘤。
- 研究结束时27例(50%)患者存在多发脑膜瘤。
临床怎么用
- 对放射性脑膜瘤患者应主动监测生长速率,避免对所有肿瘤立即手术。
- 手术应保留给出现症状或快速生长的脑膜瘤。
- 术后需密切随访,因进展风险高,中位进展时间28个月。
局限性
- 回顾性研究设计。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Radiation induced meningioma (RIM) incidence is increasing in line with improved childhood cancer survival. No optimal management strategy consensus exists. This study aimed to delineate meningioma growth rates from tumor discovery and correlate with clinical outcomes. METHODS: Retrospective study of patients with a RIM, managed at a specialist tertiary neuroscience center (2007-2019). Tumor volume was measured from diagnosis and at subsequent interval scans. Meningioma growth rate was determined using a linear mixed-effects model. Clinical outcomes were correlated with growth rates accounting for imaging and clinical prognostic factors. RESULTS: Fifty-four patients (110 meningiomas) were included. Median duration of follow-up was 74 months (interquartile range [IQR], 41-102 months). Mean radiation dose was 41 Gy (standard deviation [SD] = 14.9) with a latency period of 34.4 years (SD = 13.7). Median absolute growth rate was 0.62 cm3/year and the median relative growth rate was 72%/year. Forty meningiomas (between 27 patients) underwent surgical intervention after a median follow-up duration of 4 months (IQR 2-35). Operated RIMs were clinically aggressive, likely to be WHO grade 2 at first resection (43.6%) and to progress after surgery (41%). Median time to progression was 28 months (IQR 13-60.5). A larger meningioma at discovery was associated with growth (HR 1.2 [95% CI 1.0-1.5], P = 0.039) but not progression after surgery (HR 2.2 [95% CI 0.7-6.6], P = 0.181). Twenty-seven (50%) patients had multiple meningiomas by the end of the study. CONCLUSION: RIMs exhibit high absolute and relative growth rates after discovery. Surgery is recommended for symptomatic or rapidly growing meningiomas only. Recurrence risk after surgery is high.
引用
- Gillespie CS, Islim AI, Taweel BA, et al. The growth rate and clinical outcomes of radiation induced meningioma undergoing treatment or active monitoring. J Neurooncol. 2021. PMID: 33886110. doi:10.1007/s11060-021-03761-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。